Abstract
Recurrence of hepatitis C virus (HCV) after living donor liver transplantation was investigated using technetium-99m- diethylenetriaminepentaacetic acid-galactosyl human serum albumin (Tc-99m-GSA) liver scintigraphy. Four patients with decompensated cirrhosis due to HCV infection were retrospectively reviewed in this study. Scintigraphy was performed to determine the hepatic uptake ratio of the tracer corrected for disappearance from the blood, as well as the maximal removal rate of the tracer by hepatocytes, as parameters of hepatic functional reserve. In all patients, serum HCV ribonucleic acid (RNA) was detected 3 months after transplantation. The corrected hepatic uptake ratio and removal rate showed little change after transplantation in two patients without the recurrence of HCV infection. In another two patients, these levels were decreased at 3 months after transplantation. In one patient, recurrent HCV infection was diagnosed by confirmatory histologic examination at 12 months after transplantation. In the other patient, both levels declined further at 8 months. Although treatment was initiated with a combination of interferon plus ribavirin, this patient died of progressive hepatic failure. In conclusion, a decrease in scintigraphic parameters at 3 months after transplantation suggests recurrent HCV infection affecting the graft. Tc-99m-GSA liver scintigraphy is a useful noninvasive method for evaluating graft functional reserve.
Similar content being viewed by others
References
Baltz AC, Trotter JF (2003) Living donor liver transplantation and hepatitis C. Clin Liver Dis 7:651–665
Gane EJ, Portmann BC, Naoumov NV, et al. (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334:815–820
Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR (2002) The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122:889–896
Berenguer M, Ferrell L, Watson J, et al. (2000) HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32:673–684
Samuel D, Bizollon T, Feray C, et al. (2003) Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 124:642–650
Burgess JB, Baenziger JU, Brown WR (1992) Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology 15:702–706
Ha-Kawa SK, Tanaka Y, Hasebe S, et al. (1997) Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J Nucl Med 24:130–137
Tomiguchi S, Kira T, Oyama Y, et al. (1995) Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis. Clin Nucl Med 20:717–720
Kiuchi T, Uemoto S, Egawa H, et al. (2001) Living donor liver transplantation in Kyoto, 2001. Clin Transpl :195–201
Ishak K, Baptista A, Bianchi L, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699
Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289–293
Ha-Kawa SK, Suga Y, Ikeda K, Nagata K, Murata T, Tanaka Y (1993) Usefulness of blood disappearance corrected hepatic uptake ratio (LHL/HH) as a hepatic functional index using 99mTc-galactosyl serum albumin. Kakuigaku 30:1333–1339 (in Japanese with English abstract)
Ha-Kawa SK, Tanaka Y (1991) A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med 32:2233–2240
Kira T, Tomiguchi S, Takahashi M, Yoshimatsu S, Sagara K, Kurano R (1999) Correlation of 99mTC-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med 17:125–130
Troppmann C, Rossaro L, Perez RV, McVicar JP (2003) Early, rapidly progressive cholestatic hepatitis C reinfection and graft loss after adult living donor liver transplantation. Am J Transpl 3:239–240
Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R (2004) Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 10:340–346
Van Vierberghe H, Troisi R, Colle I, Ricciardi S, Praet M, de Hemptinne B (2004) Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation 77:210–214
Mazzaferro V, Tagger A, Schiavo M, et al. (2001) Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. Transplant Proc 33:1355–1357
Sugawara Y, Makuuchi M, Matsui Y, et al. (2004) Preemptive therapy for hepatitis C virus after living-donor liver transplantation. Transplantation 78:1308–1311
Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y (1997) Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 25:426–429
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaibori, M., Ha-Kawa, S.K., Uchida, Y. et al. Recurrent Hepatitis C After Living Donor Liver Transplantation Detected by Tc-99m GSA Liver Scintigraphy. Dig Dis Sci 51, 2013–2017 (2006). https://doi.org/10.1007/s10620-006-9534-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9534-1